Inogen, Inc. (INGN) Stock Price & Analysis
Inogen, Inc. (INGN) closed at USD 6.3 on Thursday, October 15, 2026, up 2.69% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 6.13; the Oct 15, 2026 session ranged USD 6.2–6.37 on volume of 161,011 shares. Market capitalization is $167.06M, with a 52-week range of USD 5.05–9.13 (NMS). Source: Nexqual, retrieved October 16, 2026 at 05:20 UTC.
Also available as compact Markdown for AI agents: nexqual.com/INGN.md
Key facts (INGN)
- Analysts: Buy (mean 1.50 on a 1–5 scale) (2 analysts), mean target USD 12 (range 12–12).
- Total return with dividends: 1Y -26.0% vs S&P 500 +18.1%; 5Y -84.6% vs S&P 500 +85.1%.
- Next earnings: 2026-11-05, EPS estimate USD -0.06, revenue estimate $92.3M.
Analysts (INGN)
Consensus Buy (mean 1.50 on a 1–5 scale), 2 analysts; mean target USD 12 (low 12, high 12).
Total return (dividends reinvested) (INGN)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | -26.0% | -84.6% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -26.1% | -31.1% |
| Volatility (annualized) | 44.0% | 59.3% |
| Max drawdown | -43.1% (Oct 2025→Sep 2026) | -89.8% (Oct 2021→Oct 2023) |
Key Statistics (as of October 16, 2026 at 05:20 UTC)
| Price | USD 6.3 |
|---|---|
| Change | ▲ 2.69% (up) |
| Previous Close | USD 6.13 |
| Open | USD 6.2 |
| Day Range | USD 6.2 – 6.37 |
| 52-Week Range | USD 5.05 – 9.13 |
| Volume | 161,011 shares |
| Market Cap | $167.06M |
| Exchange | NMS |
Technical Analysis (INGN)
Nexqual's technical model rates INGN "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of October 16, 2026 at 05:20 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 64.42 (neutral) |
| vs SMA50 | Above (USD 5.61) |
| MACD | 0.21 (positive) |
Analyst Ratings (INGN)
Wall Street analysts rate INGN "Buy" based on 2 analysts, with a mean price target of USD 12 (range USD 12–12), per Nexqual as of October 16, 2026 at 05:20 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 12 |
| High Target | USD 12 |
| Low Target | USD 12 |
| Buy / Hold / Sell | 2 / 0 / 0 |
Earnings (INGN)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD -0.06 |
| Revenue Estimate | $92.25M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0 vs est -0.06 ▲ beat |
| 2026-03-31 | USD -0.14 vs est -0.21 ▲ beat |
| 2025-12-31 | USD -0.15 vs est -0.18 ▲ beat |
| 2025-09-30 | USD -0.02 vs est -0.09 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:20 UTC.
Financials & Fundamentals (INGN)
| Total Revenue | $354.30M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +3.00% |
| Gross Margin | +44.51% |
| Operating Margin | -5.13% |
| Profit Margin | -6.94% |
| ROE | -13.14% |
| Debt / Equity | 0.09 |
| Current Ratio | 2.74 |
| Total Cash | $105.54M |
| Total Debt | $15.79M |
Source: Nexqual, October 16, 2026 at 05:20 UTC.
Financial Health Score (INGN)
Nexqual rates Inogen, Inc.'s overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:20 UTC.
| Growth | Mixed — Revenue +3.9% YoY (annual), slow |
|---|---|
| Profitability | Mixed — Gross margin 45%, operating -5% |
| Balance Sheet | Strong — $106M cash vs $16M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$3M (TTM) |
| Efficiency | Critical — ROE -13%, ROA -5.8% |
Ownership (INGN)
| Insider Ownership | +12.95% |
|---|---|
| Institutional Ownership | +80.31% |
| Shares Outstanding | 26.54M |
| Float | 23.13M |
| Short % of Float | +5.66% |
Source: Nexqual, October 16, 2026 at 05:20 UTC.
Leadership (INGN)
Inogen, Inc. is led by Kevin R. M. Smith (age 54), President, CEO & Director, per Nexqual as of October 16, 2026 at 05:20 UTC.
| President, CEO & Director | Kevin R. M. Smith (age 54) |
|---|---|
| CFO, Executive VP & Treasurer | Jason A. Richardson (age 48) |
| Executive VP & COO | Andrew P. Reding (age 55) |
| Chief Technology Officer | Naga Rameswamy |
| Senior Vice President of Investor Relations | Lorna Williams |
Major Backers & Investors (INGN)
Notable institutional backers of Inogen, Inc. include Acadian Asset Management. LLC, Armistice Capital, LLC, Ameriprise Financial, Inc., according to Nexqual as of October 16, 2026 at 05:20 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Acadian Asset Management. LLC | 4.13% |
| Armistice Capital, LLC | 4.13% |
| Ameriprise Financial, Inc. | 3.7% |
| AQR Capital Management, LLC | 3.53% |
| DAFNA Capital Management, LLC | 3.18% |
| Arrowstreet Capital, Limited Partnership | 2.8% |
| Morgan Stanley | 2.44% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 9.8% |
| Vanguard Group | 8.18% |
| Columbia Threadneedle | 2.43% |
Source: Nexqual, October 16, 2026 at 05:20 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ESTA | Establishment Labs Holdings Inc | USD 61.36 | ▲ 4.98% |
| ALMR | Alamar Biosciences, Inc. | USD 27.42 | ▲ 16.58% |
| INSP | Inspire Medical Systems, Inc. | USD 70.12 | ▲ 1.83% |
| BFLY | Butterfly Network, Inc. | USD 7.85 | ▼ 3.09% |
| AXGN | AxoGen, Inc. | USD 35.63 | ▼ 1.49% |
| UFPT | UFP Technologies, Inc. | USD 297.19 | ▲ 0.99% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:20 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt